153 related articles for article (PubMed ID: 31664951)
1. Furosemide use and survival in patients with esophageal or gastric cancer: a population-based cohort study.
Liu P; McMenamin ÚC; Spence AD; Johnston BT; Coleman HG; Cardwell CR
BMC Cancer; 2019 Oct; 19(1):1017. PubMed ID: 31664951
[TBL] [Abstract][Full Text] [Related]
2. Low-Dose Aspirin Use Does Not Increase Survival in 2 Independent Population-Based Cohorts of Patients With Esophageal or Gastric Cancer.
Spence AD; Busby J; Johnston BT; Baron JA; Hughes CM; Coleman HG; Cardwell CR
Gastroenterology; 2018 Mar; 154(4):849-860.e1. PubMed ID: 29122547
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin receptor blocker use and gastro-oesophageal cancer survival: a population-based cohort study.
Busby J; McMenamin Ú; Spence A; Johnston BT; Hughes C; Cardwell CR
Aliment Pharmacol Ther; 2018 Jan; 47(2):279-288. PubMed ID: 29105106
[TBL] [Abstract][Full Text] [Related]
4. Statin use and survival in patients with gastric cancer in two independent population-based cohorts.
Spence AD; Busby J; Hughes CM; Johnston BT; Coleman HG; Cardwell CR
Pharmacoepidemiol Drug Saf; 2019 Apr; 28(4):460-470. PubMed ID: 30456916
[TBL] [Abstract][Full Text] [Related]
5. Survival of esophageal and gastric cancer patients with adjuvant and palliative chemotherapy-a retrospective analysis of a register-based patient cohort.
Ekheden I; Ebrahim F; Ólafsdóttir H; Raaschou P; Wettermark B; Henriksson R; Ye W
Eur J Clin Pharmacol; 2020 Jul; 76(7):1029-1041. PubMed ID: 32372150
[TBL] [Abstract][Full Text] [Related]
6. Association Between Statin Use After Diagnosis of Esophageal Cancer and Survival: A Population-Based Cohort Study.
Alexandre L; Clark AB; Bhutta HY; Chan SS; Lewis MP; Hart AR
Gastroenterology; 2016 Apr; 150(4):854-65.e1; quiz e16-7. PubMed ID: 26775632
[TBL] [Abstract][Full Text] [Related]
7. Selective serotonin reuptake inhibitor use and breast cancer survival: a population-based cohort study.
Busby J; Mills K; Zhang SD; Liberante FG; Cardwell CR
Breast Cancer Res; 2018 Jan; 20(1):4. PubMed ID: 29351761
[TBL] [Abstract][Full Text] [Related]
8. Impact of metformin on gastric adenocarcinoma survival: A Belgian population based study.
Lacroix O; Couttenier A; Vaes E; Cardwell CR; De Schutter H; Robert A
Cancer Epidemiol; 2018 Apr; 53():149-155. PubMed ID: 29453032
[TBL] [Abstract][Full Text] [Related]
9. Demographic and lifestyle factors and survival among patients with esophageal and gastric cancer: The Biobank Japan Project.
Okada E; Ukawa S; Nakamura K; Hirata M; Nagai A; Matsuda K; Ninomiya T; Kiyohara Y; Muto K; Kamatani Y; Yamagata Z; Kubo M; Nakamura Y; ; Tamakoshi A
J Epidemiol; 2017 Mar; 27(3S):S29-S35. PubMed ID: 28190659
[TBL] [Abstract][Full Text] [Related]
10. Relationship between aspirin use of esophageal, gastric and colorectal cancer patient survival: a meta-analysis.
Lin JL; Lin JX; Zheng CH; Li P; Xie JW; Wang JB; Lu J; Chen QY; Cao LL; Lin M; Huang CM
BMC Cancer; 2020 Jul; 20(1):638. PubMed ID: 32646396
[TBL] [Abstract][Full Text] [Related]
11. Statin use after diagnosis is associated with an increased survival in esophageal cancer patients: a Belgian population-based study.
Lacroix O; Couttenier A; Vaes E; Cardwell CR; De Schutter H; Robert A
Cancer Causes Control; 2019 Apr; 30(4):385-393. PubMed ID: 30820714
[TBL] [Abstract][Full Text] [Related]
12. Statin use after esophageal cancer diagnosis and survival: A population based cohort study.
Cardwell CR; Spence AD; Hughes CM; Murray LJ
Cancer Epidemiol; 2017 Jun; 48():124-130. PubMed ID: 28486205
[TBL] [Abstract][Full Text] [Related]
13. Use of Acid-Suppressant Medications After Diagnosis Increases Mortality in a Subset of Gastrointestinal Cancer Patients.
Ayyagari S; Tan MC; Liu Y; El-Serag HB; Thrift AP
Dig Dis Sci; 2020 Sep; 65(9):2691-2699. PubMed ID: 31802383
[TBL] [Abstract][Full Text] [Related]
14. Socio-demographic and geographical factors in esophageal and gastric cancer mortality in Sweden.
Ljung R; Drefahl S; Andersson G; Lagergren J
PLoS One; 2013; 8(4):e62067. PubMed ID: 23637965
[TBL] [Abstract][Full Text] [Related]
15. Prognostic impact of angiotensin-converting enzyme inhibitors and angiotensin receptors blockers in esophageal or gastric cancer patients with hypertension - a real-world study.
Li PC; Huang RY; Yang YC; Hsieh KP; Yang YH
BMC Cancer; 2022 Apr; 22(1):430. PubMed ID: 35443635
[TBL] [Abstract][Full Text] [Related]
16. Risk of malignant progression in Barrett's esophagus patients: results from a large population-based study.
Bhat S; Coleman HG; Yousef F; Johnston BT; McManus DT; Gavin AT; Murray LJ
J Natl Cancer Inst; 2011 Jul; 103(13):1049-57. PubMed ID: 21680910
[TBL] [Abstract][Full Text] [Related]
17. Association between oral leukoplakia and risk of upper gastrointestinal cancer death: A follow-up study of the Linxian General Population Trial.
Liang H; Yang Z; Wang JB; Yu P; Fan JH; Qiao YL; Taylor PR
Thorac Cancer; 2017 Nov; 8(6):642-648. PubMed ID: 28929584
[TBL] [Abstract][Full Text] [Related]
18. Metabolic syndrome and esophageal and gastric cancer.
Lin Y; Ness-Jensen E; Hveem K; Lagergren J; Lu Y
Cancer Causes Control; 2015 Dec; 26(12):1825-34. PubMed ID: 26450604
[TBL] [Abstract][Full Text] [Related]
19. Failure-to-rescue in patients undergoing surgery for esophageal or gastric cancer.
Busweiler LA; Henneman D; Dikken JL; Fiocco M; van Berge Henegouwen MI; Wijnhoven BP; van Hillegersberg R; Rosman C; Wouters MW; van Sandick JW;
Eur J Surg Oncol; 2017 Oct; 43(10):1962-1969. PubMed ID: 28797755
[TBL] [Abstract][Full Text] [Related]
20. Waiting time for cancer treatment and mental health among patients with newly diagnosed esophageal or gastric cancer: a nationwide cohort study.
Song H; Fang F; Valdimarsdóttir U; Lu D; Andersson TM; Hultman C; Ye W; Lundell L; Johansson J; Nilsson M; Lindblad M
BMC Cancer; 2017 Jan; 17(1):2. PubMed ID: 28049452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
